188 related articles for article (PubMed ID: 31965981)
61. Differential hypoxic regulation of hypoxia-inducible factors 1alpha and 2alpha.
Lin Q; Cong X; Yun Z
Mol Cancer Res; 2011 Jun; 9(6):757-65. PubMed ID: 21571835
[TBL] [Abstract][Full Text] [Related]
62. Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition.
Jampasri S; Reabroi S; Tungmunnithum D; Parichatikanond W; Pinthong D
Molecules; 2022 Sep; 27(17):. PubMed ID: 36080483
[TBL] [Abstract][Full Text] [Related]
63. Phorbol ester stimulates the nonhypoxic induction of a novel hypoxia-inducible factor 1alpha isoform: implications for tumor promotion.
Chun YS; Lee KH; Choi E; Bae SY; Yeo EJ; Huang LE; Kim MS; Park JW
Cancer Res; 2003 Dec; 63(24):8700-7. PubMed ID: 14695184
[TBL] [Abstract][Full Text] [Related]
64. Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer.
Kazi AA; Gilani RA; Schech AJ; Chumsri S; Sabnis G; Shah P; Goloubeva O; Kronsberg S; Brodie AH
Breast Cancer Res; 2014 Jan; 16(1):R15. PubMed ID: 24472707
[TBL] [Abstract][Full Text] [Related]
65. Computer Analysis of Glioma Transcriptome Profiling: Alternative Splicing Events.
Babenko VN; Gubanova NV; Bragin AO; Chadaeva IV; Vasiliev GV; Medvedeva IV; Gaytan AS; Krivoshapkin AL; Orlov YL
J Integr Bioinform; 2017 Sep; 14(3):. PubMed ID: 28918420
[TBL] [Abstract][Full Text] [Related]
66. MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer.
Niu Y; Jin Y; Deng SC; Deng SJ; Zhu S; Liu Y; Li X; He C; Liu ML; Zeng Z; Chen HY; Zhong JX; Ye Z; Wang CY; Zhao G
Oncogene; 2018 Mar; 37(13):1743-1758. PubMed ID: 29343850
[TBL] [Abstract][Full Text] [Related]
67. Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding.
Jones DT; Harris AL
Mol Cancer Ther; 2006 Sep; 5(9):2193-202. PubMed ID: 16985052
[TBL] [Abstract][Full Text] [Related]
68. Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.
Zhang C; Zhi WI; Lu H; Samanta D; Chen I; Gabrielson E; Semenza GL
Oncotarget; 2016 Oct; 7(40):64527-64542. PubMed ID: 27590511
[TBL] [Abstract][Full Text] [Related]
69. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
70. LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1α.
Xu L; Huan L; Guo T; Wu Y; Liu Y; Wang Q; Huang S; Xu Y; Liang L; He X
Oncogene; 2020 Nov; 39(46):7005-7018. PubMed ID: 33060856
[TBL] [Abstract][Full Text] [Related]
71. Transcriptome-wide analysis and modelling of prognostic alternative splicing signatures in invasive breast cancer: a prospective clinical study.
Wang L; Wang Y; Su B; Yu P; He J; Meng L; Xiao Q; Sun J; Zhou K; Xue Y; Tan J
Sci Rep; 2020 Oct; 10(1):16504. PubMed ID: 33020551
[TBL] [Abstract][Full Text] [Related]
72. Hypoxia-responsive miR-141-3p is involved in the progression of breast cancer via mediating the HMGB1/HIF-1α signaling pathway.
Sun S; Ma J; Xie P; Wu Z; Tian X
J Gene Med; 2020 Oct; 22(10):e3230. PubMed ID: 32436353
[TBL] [Abstract][Full Text] [Related]
73. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448
[TBL] [Abstract][Full Text] [Related]
74. Anterior gradient 2 promotes tumorigenesis through upregulation of CCAAT-enhancer binding protein beta and hypoxia-inducible factor-2α and subsequent secretion of interleukin-6, interleukin-8, and vascular endothelial growth factor in the Caki-1 clear cell renal cell carcinoma cell line.
Pajdzik K; Wilamowski M; Żurawek D; Stopa KB; Nodzyński M; Kalita A; Jura J
IUBMB Life; 2020 Aug; 72(8):1807-1818. PubMed ID: 32593213
[TBL] [Abstract][Full Text] [Related]
75. Genome-wide analysis reveals the association between alternative splicing and DNA methylation across human solid tumors.
Sun X; Tian Y; Wang J; Sun Z; Zhu Y
BMC Med Genomics; 2020 Jan; 13(1):4. PubMed ID: 31906954
[TBL] [Abstract][Full Text] [Related]
76. Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.
Bemmo A; Dias C; Rose AA; Russo C; Siegel P; Majewski J
PLoS One; 2010 Aug; 5(8):e11981. PubMed ID: 20700505
[TBL] [Abstract][Full Text] [Related]
77. CITED4 inhibits hypoxia-activated transcription in cancer cells, and its cytoplasmic location in breast cancer is associated with elevated expression of tumor cell hypoxia-inducible factor 1alpha.
Fox SB; Bragança J; Turley H; Campo L; Han C; Gatter KC; Bhattacharya S; Harris AL
Cancer Res; 2004 Sep; 64(17):6075-81. PubMed ID: 15342390
[TBL] [Abstract][Full Text] [Related]
78. MiR-200c downregulates HIF-1α and inhibits migration of lung cancer cells.
Byun Y; Choi YC; Jeong Y; Lee G; Yoon S; Jeong Y; Yoon J; Baek K
Cell Mol Biol Lett; 2019; 24():28. PubMed ID: 31061665
[TBL] [Abstract][Full Text] [Related]
79. Yak response to high-altitude hypoxic stress by altering mRNA expression and DNA methylation of hypoxia-inducible factors.
Xiong X; Fu M; Lan D; Li J; Zi X; Zhong J
Anim Biotechnol; 2015; 26(3):222-9. PubMed ID: 25927169
[TBL] [Abstract][Full Text] [Related]
80. Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition.
Maunakea AK; Chepelev I; Cui K; Zhao K
Cell Res; 2013 Nov; 23(11):1256-69. PubMed ID: 23938295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
